Display options
Cite
Segura J, Christiansen H, Campo C, et al. How to titrate ACE inhibitors and angiotensin receptor blockers in renal patients: according to blood pressure or proteinuria?. Curr Hypertens Rep. 2003;5(5):426-9doi: 10.1007/s11906-003-0089-7.
Segura, J., Christiansen, H., Campo, C., & Ruilope, L. M. (2003). How to titrate ACE inhibitors and angiotensin receptor blockers in renal patients: according to blood pressure or proteinuria?. Current hypertension reports, 5(5), 426-9. https://doi.org/10.1007/s11906-003-0089-7
Segura, Julian, et al. "How to titrate ACE inhibitors and angiotensin receptor blockers in renal patients: according to blood pressure or proteinuria?." Current hypertension reports vol. 5,5 (2003): 426-9. doi: https://doi.org/10.1007/s11906-003-0089-7
Segura J, Christiansen H, Campo C, Ruilope LM. How to titrate ACE inhibitors and angiotensin receptor blockers in renal patients: according to blood pressure or proteinuria?. Curr Hypertens Rep. 2003 Oct;5(5):426-9. doi: 10.1007/s11906-003-0089-7. PMID: 12948436.
Copy Download .nbib Format: NLM
Share it on

Curr Hypertens Rep. 2003 Oct;5(5):426-9. doi: 10.1007/s11906-003-0089-7.

How to titrate ACE inhibitors and angiotensin receptor blockers in renal patients: according to blood pressure or proteinuria?.

Current hypertension reports

Julian Segura, Helle Christiansen, Carlos Campo, Luis M Ruilope

Affiliations

  1. Hypertension Unit, Hospital 12 de Octubre, Av. Córdoba s/n, 28041 Madrid, Spain.

PMID: 12948436 DOI: 10.1007/s11906-003-0089-7

Abstract

The inhibition of the effects of angiotensin II is necessary to ensure the best degree of renal protection by the simultaneous control of blood pressure (BP) and the achievement of the maximal antiproteinuric capacity. The inhibition can be attained through the administration of either an angiotensin-converting enzyme (ACE) inhibitor or an angiotensin II receptor blocker (ARB). Uptitration of antihypertensive therapy is frequently required to achieve the desired BP goal in patients presenting with renal disease, with or without proteinuria. Control of BP is good for both cardiovascular and renal protection. Sometimes, in particular when BP levels are high in the absence of therapy, the simple control of BP without inhibiting the renin- angiotensin system can be accompanied by a significant drop in proteinuria. On the other hand, the possibility that an ACE inhibitor or an ARB diminishes protein excretion in urine in the absence of changes in BP has been considered after the known evidence that these classes of drugs are renoprotective independently of their effect on BP control. The aim of this paper is to briefly review the evidence in favor of uptitration of either class of inhibitors of the renin-angiotensin system as compared with the combination of the two for the control of either BP or proteinuria.

References

  1. Nephrol Dial Transplant. 2003 Feb;18(2):293-7 - PubMed
  2. Curr Opin Nephrol Hypertens. 1998 Mar;7(2):145-8 - PubMed
  3. Nephrol Dial Transplant. 1993;8(7):582-4 - PubMed
  4. J Hypertens. 2002 Apr;20(4):729-37 - PubMed
  5. Lancet. 2003 Jan 11;361(9352):117-24 - PubMed
  6. Hypertension. 2001 Sep;38(3 Pt 2):537-42 - PubMed
  7. J Am Coll Cardiol. 2001 Dec;38(7):1782-7 - PubMed
  8. Ann Intern Med. 2002 Apr 16;136(8):604-15 - PubMed
  9. Diabetes Care. 2003 Jan;26(1):172-8 - PubMed
  10. Kidney Int. 2002 Mar;61(3):1086-97 - PubMed
  11. Ann Intern Med. 1995 Nov 15;123(10):754-62 - PubMed
  12. J Hypertens. 2003 Jun;21(6):1011-53 - PubMed
  13. Kidney Int. 2002 Sep;62(3):1020-5 - PubMed
  14. JAMA. 2001 Jun 6;285(21):2719-28 - PubMed
  15. J Renin Angiotensin Aldosterone Syst. 2003 Mar;4(1):43-7 - PubMed
  16. J Hum Hypertens. 2003 Jan;17(1):7-12 - PubMed
  17. Curr Hypertens Rep. 2002 Oct;4(5):365-8 - PubMed
  18. J Am Soc Nephrol. 2001 Feb;12(2):218-25 - PubMed
  19. J Renin Angiotensin Aldosterone Syst. 2000 Sep;1(3):217-33 - PubMed
  20. Diabetes Care. 2003 Jan;26(1):150-5 - PubMed
  21. Nephrol Dial Transplant. 2002 Aug;17(8):1413-8 - PubMed
  22. J Am Soc Nephrol. 2002 Jul;13(7):1733-9 - PubMed
  23. JAMA. 2003 May 21;289(19):2560-72 - PubMed
  24. J Am Soc Nephrol. 2002 Nov;13 Suppl 3:S165-8 - PubMed
  25. Hypertension. 1999 Dec;34(6):1281-6 - PubMed
  26. Lancet. 1974 Jun 15;1(7868):1190-2 - PubMed

Substances

MeSH terms

Publication Types